A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Dasatinib
Related studies linked through entity extraction aliases.
Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib (Sprycelâ„¢) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Personalized Treatment Selection for Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib
- Status
- COMPLETED
- Phase
- PHASE2
Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2